Chapter 34 ■ Management of Vascular Spasm and Thrombosis 229

5. Roy M, Turner- Gomes S, Gill G, et al. Accuracy of Doppler

ultrasonography for the diagnosis of thrombosis associated with

umbilical venous catheters. J Pediatr. 2002; 140: 131.

6. Manco- Johnson MJ, Grabowski EF, Hellgreen M, et al.

Laboratory testing for thrombophilia in pediatric patients. On

behalf of the Subcommittee for Perinatal and Pediatric

Thrombosis of the Scientific and Standardization Committee of

the International Society of Thrombosis and Haemostasis (ISTH).

Thromb Haemost. 2002;88:155.

7. Raffini L. Thrombophilia in children: who to test, how, when

and why? Hematology Am Soc Hematol Educ Program. 2008:

228.

8. Yang JYK, Chan AKC. Neonatal systemic venous thrombosis.

Thrombosis Res. 2010;126:471.

9. Wong AF, McCulloch LM, Sola A. Treatment of peripheral tissue

ischemia with topical nitroglycerine ointment in neonates.

J Pediatr. 1992;121:980.

10. Vasquez P, Burd A, Mehta R, et al. Resolution of peripheral artery

catheter induced ischemic injury following prolonged treatment

with topical nitroglycerine ointment in a newborn: a case report.

J Perinatol. 2003:23:348

11. Baserga MC, Puri A, Sola A. The use of topical nitroglycerine

ointment to treat peripheral tissue ischemia secondary to arterial

line complications in neonates. J Perinatol. 2002;22:416.

12. Monagle P, Chalmers E, Chan A, et al. Antithrombotic therapy

in neonates and children: American College of Chest Physicians

Evidence Based Clinical Practice Guidelines (8th edition). Chest.

2008;133:887S.

13. Saxonhouse MA. Management of neonatal thrombosis. Clin

Perinatol. 2012;39:191.

14. Albisetti M. Thrombolytic therapy in children. Thromb Res.

2006;118:95.

15. Kumar P, Hoppensteadt DA, Prechel MM, et al. Prevalence of

heparin- dependent platelet activating antibodies in preterm newborns after exposure to unfractionated heparin. Clin Appl Thromb

Hemost. 2004;10:335.

16. Streiff W, Goebel G, Chan AKC, et al. Use of low molecular

weight heparin (enoxaparin) in newborn infants: a prospective

cohort study of 62 patients. Arch Dis Child Fetal Neonatal Ed.

2003;88:F365.

17. Malowany JI, Monagle P, Knoppert DC, et al. Enoxaparin for

neonatal thrombosis: a call for a higher dose for neonates. Thromb

Res. 2008;122:826.

18. Wiernikowski JT, Chan A, Lo G. Reversal of anti- thrombin activity using protamine sulphate. Experience in a neonate with a 10

fold overdose of enoxaparin. Thromb Res. 2007;120:303.

19. Raffini L. Thrombolysis for intravascular thrombosis in neonates.

Curr Opin Pediatr. 2009;21:9.

20. Williams MD. Thrombolysis in children. Br J Haematol. 2009;

148:26.

21. Zenz W, Arlt F, Sodia S, et al. Intracerebral hemorrhage during

fibrinolytic therapy in children. A review of literature of the last

thirty years. Semin Thromb Hemost. 1997;23:321.

22. Nowak- Gottl U, Auberger K, Halimeh S, et al. Thrombolysis in

newborns and infants. Thromb Haemost. 1999;82(suppl):112.

23. Yang JY, Williams S, Brando LR, et al. Neonatal and childhood

right atrial thrombosis: recognition and a risk-stratified treatment

approach. Blood Coagul Fibrinolysis. 2020;21:301.

24. Coombs CJ, Richardson PW, Dowling GJ, et al. Brachial artery

thrombosis in infants: an algorithm for limb salvage. Plast Reconstr

Surg. 2006;117:1481.

25. Ade-Ajayi N, Hall NJ, Liesner R, et al. Acute neonatal arterial

occlusion: is thrombolysis safe and effective? J Pediatr Surg.

2008;43:1827.

230

35 Bubble Nasal Continuous Positive Airway Pressure

36 Endotracheal Intubation

VI Respiratory Care